|
Aditxt Inc (NASDAQ: ADTX) |
|
Aditxt Inc
ADTX's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Aditxt Inc 's sales fell
by -79.73 % in the second quarter of 2024 from the same quarter a year ago.
Ranking at No. 1880
Major Pharmaceutical Preparations industry recorded
growth of revenues by 5.18 %
Aditxt Inc net loss increased from $-6 millions, to $-8 millions in second quarter of 2024,
• More on ADTX's Growth
|
|
Aditxt Inc realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 0.01 in trailing twelve-month period. |
Company |
-0 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.02.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.48.
• More on ADTX's Valuation
|
|
|
|
|
Aditxt Inc realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 0.01 in trailing twelve-month period. |
Company |
-0 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.02.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.48.
Aditxt Inc Price to Book Ratio is at 0 lower than Industry Avg. of 35.08. and lower than S&P 500 Avg. of 0.01
• More on ADTX's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com